Literature DB >> 19009648

Ghrelin and gastric acid secretion.

Koji Yakabi1, Junichi Kawashima, Shingo Kato.   

Abstract

Ghrelin, a novel growth hormone-releasing peptide, was originally isolated from rat and human stomach. Ghrelin has been known to increase the secretion of growth hormone (GH), food intake, and body weight gain when administered peripherally or centrally. Ghrelin is also known to stimulate the gastric motility and the secretion of gastric acid. In the previous studies, the action of ghrelin on acid secretion was shown to be as strong as that of histamine and gastrin in in-vivo experiment. In the studies, the mechanism for the action of ghrelin was also investigated. It was shown that vagotomy completely inhibited the action of ghrelin on the secretion of gastric acid suggesting that vagal nerve is involved in the mechanism for the action of ghrelin on acid secretion. As famotidine did not inhibit ghrelin-induced acid secretion in the study by Masuda et al, they concluded that histamine was not involved in the action of ghrelin on acid secretion. However, we have shown that famotidine completely inhibited ghrelin-induced acid secretion and histidine decarboxylase (HDC) mRNA was increased in gastric mucosa by ghrelin injection which is inhibited by vagotomy Our results indicate that histamine is involved in the action of ghrelin on acid secretion. Furthermore synergistic action of gastrin and ghrelin on gastric acid secretion was shown. Although gastrin has important roles in postprandial secretion of gastric acid, ghrelin may be related to acid secretion during fasting period or at night. However, further studies are needed to elucidate the physiological role of ghrelin in acid secretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19009648      PMCID: PMC2766114          DOI: 10.3748/wjg.14.6334

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.

Authors:  M Shintani; Y Ogawa; K Ebihara; M Aizawa-Abe; F Miyanaga; K Takaya; T Hayashi; G Inoue; K Hosoda; M Kojima; K Kangawa; K Nakao
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin.

Authors:  A Asakawa; A Inui; T Kaga; H Yuzuriha; T Nagata; N Ueno; S Makino; M Fujimiya; A Niijima; M A Fujino; M Kasuga
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

3.  Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression.

Authors:  J Kamegai; H Tamura; T Shimizu; S Ishii; H Sugihara; I Wakabayashi
Journal:  Endocrinology       Date:  2000-12       Impact factor: 4.736

4.  Histamine mediates the stimulatory action of ghrelin on acid secretion in rat stomach.

Authors:  Koji Yakabi; Shoki Ro; Tsuneko Onouhi; Teruyuki Tanaka; Shino Ohno; Seiichi Miura; Yukimi Johno; Kiyoshige Takayama
Journal:  Dig Dis Sci       Date:  2006-07-13       Impact factor: 3.199

5.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

6.  A role for ghrelin in the central regulation of feeding.

Authors:  M Nakazato; N Murakami; Y Date; M Kojima; H Matsuo; K Kangawa; S Matsukura
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

7.  The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion.

Authors:  A M Wren; C J Small; H L Ward; K G Murphy; C L Dakin; S Taheri; A R Kennedy; G H Roberts; D G Morgan; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

8.  Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans.

Authors:  Y Date; M Kojima; H Hosoda; A Sawaguchi; M S Mondal; T Suganuma; S Matsukura; K Kangawa; M Nakazato
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

9.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

10.  Ghrelin acts in the central nervous system to stimulate gastric acid secretion.

Authors:  Y Date; M Nakazato; N Murakami; M Kojima; K Kangawa; S Matsukura
Journal:  Biochem Biophys Res Commun       Date:  2001-01-26       Impact factor: 3.575

View more
  12 in total

1.  Ghrelin and gastrin in advanced gastric cancer before and after gastrectomy.

Authors:  Anna Zub-Pokrowiecka; Kazimierz Rembiasz; Peter C Konturek; Andrzej Budzyński; Stanisław J Konturek; Marek Winiarski; Władysław Bielański
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Histamine modulates γδ-T lymphocyte migration and cytotoxicity, via Gi and Gs protein-coupled signalling pathways.

Authors:  K Truta-Feles; M Lagadari; K Lehmann; L Berod; S Cubillos; S Piehler; Y Herouy; D Barz; T Kamradt; Aa Maghazachi; J Norgauer
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

Review 3.  The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.

Authors:  Artem Minalyan; Lilit Gabrielyan; David Scott; Jonathan Jacobs; Joseph R Pisegna
Journal:  Curr Gastroenterol Rep       Date:  2017-08

4.  Pharmacokinetics and pharmacodynamics of PF-05190457: The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects.

Authors:  William S Denney; Gabriele E Sonnenberg; Santos Carvajal-Gonzalez; Theresa Tuthill; V Margaret Jackson
Journal:  Br J Clin Pharmacol       Date:  2016-10-29       Impact factor: 4.335

5.  Pharmacological characterization of the first in class clinical candidate PF-05190457: a selective ghrelin receptor competitive antagonist with inverse agonism that increases vagal afferent firing and glucose-dependent insulin secretion ex vivo.

Authors:  J Kong; J Chuddy; I A Stock; P M Loria; S V Straub; C Vage; K O Cameron; S K Bhattacharya; K Lapham; K F McClure; Y Zhang; V M Jackson
Journal:  Br J Pharmacol       Date:  2016-03-17       Impact factor: 8.739

6.  Changes in serum ghrelin level in relation to meal-time in patients with functional dyspepsia.

Authors:  Mh Kazemi; A Eshraghian; L Hamidpour; Sa Taghavi
Journal:  United European Gastroenterol J       Date:  2015-02       Impact factor: 4.623

7.  Integrating GHS into the Ghrelin System.

Authors:  Johannes D Veldhuis; Cyril Y Bowers
Journal:  Int J Pept       Date:  2010-03-18

8.  Ghrelin and functional dyspepsia.

Authors:  Takashi Akamizu; Hiroshi Iwakura; Hiroyuki Ariyasu; Kenji Kangawa
Journal:  Int J Pept       Date:  2010-01-12

Review 9.  Impairment of ghrelin synthesis in Helicobacter pylori-colonized stomach: new clues for the pathogenesis of H. pylori-related gastric inflammation.

Authors:  Omero Alessandro Paoluzi; Del Vecchio Giovanna Blanco; Roberta Caruso; Ivan Monteleone; Giovanni Monteleone; Francesco Pallone
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

10.  The type 2 CCK/gastrin receptor antagonist YF476 acutely prevents NSAID-induced gastric ulceration while increasing iNOS expression.

Authors:  Dominic-Luc Webb; Tobias Rudholm-Feldreich; Linda Gillberg; Md Abdul Halim; Elvar Theodorsson; Gareth J Sanger; Colin A Campbell; Malcolm Boyce; Erik Näslund; Per M Hellström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-11-24       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.